Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas

Leuk Lymphoma. 2020 Dec;61(12):2955-2961. doi: 10.1080/10428194.2020.1790555. Epub 2020 Jul 9.

Abstract

We report results on 23 patients with cutaneous T cell lymphoma (7 primary cutaneous γδ T cell lymphoma [PCGDT], 16 mycosis fungoides/Sézary syndrome [MF/SS]) who underwent allogeneic stem cell transplantation. All pts had skin involvement, 14 had total skin electron beam before conditioning. Donors were 10/10 HLA matched related (13), 5/10 haploidentical (4), and matched unrelated (5) or mismatched unrelated (1). Thirteen were in a clinical complete remission at the time of transplant. The 100-day transplant related mortality for the MF/SS and PCGDT patients was 12% and 29%, respectively. At a median follow up of 5.5 years, the overall survival and disease-free survival for MF/SS patients was 75% and 64%, respectively, and 6 of 10 MF/SS pts in long term complete response had a partial response at the time of transplant. Of seven PCGDT patients, four of seven are alive at a median follow up of 5 years and three are disease-free.

Keywords: Mycosis fungoides; Sézary syndrome; allogeneic stem cell transplant; primary cutaneous gamma delta t cell lymphoma; reduced intensity transplantation.

MeSH terms

  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Intraepithelial Lymphocytes*
  • Lymphoma, T-Cell, Cutaneous* / therapy
  • Mycosis Fungoides* / diagnosis
  • Mycosis Fungoides* / therapy
  • Sezary Syndrome*
  • Skin Neoplasms* / therapy
  • Transplantation, Homologous
  • Treatment Outcome